Recruiting Heart Attack Studies in Ghent
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
The primary objective of the FALCON study is to evaluate the efficacy of KL1333 on selected disease manifestations of primary mitochondrial disease (PMD) following 48 weeks of treatment. This objectiv...
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
The main purpose of this study is to evaluate the effect and safety of efgartigimod PH20 SC compared to placebo in adults with systemic sclerosis. The study consists of a screening period, a treatment...
Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age
A study to evaluate the pharmacodynamic effects, safety, and tolerability of patiromer in children under 12 years of age with hyperkalaemia...
About Heart Attack Clinical Trials in Ghent
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 3 heart attack clinical trials recruiting participants in Ghent, . These studies are seeking a combined 297 participants. Research is being sponsored by Abliva AB, argenx, Vifor Pharma, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Ghent — FAQ
Are there heart attack clinical trials in Ghent?
Yes, there are 3 heart attack clinical trials currently recruiting in Ghent, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Ghent?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ghent research site will contact you about next steps.
Are clinical trials in Ghent free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ghent studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 3 active trials in Ghent are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov